Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis

International Journal of Cardiology

Volumn 136, Issue 2, 2009, Pages 186-192

  Ruigómez, Ana ^a   Johansson, Saga ^b,c   Wallander, Mari Ann ^b,d   Edvardsson, Nils ^b,e   García Rodríguez, Luis Alberto ^a  

^a Department of Pharmacoepidemiology   (Spain)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atrial fibrillation; Coronary event; Epidemiology; Heart failure; Ischemic cerebrovascular accident; Primary health care

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HIGH RISK PATIENT; HUMAN; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE;

EID: 67650960979     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.04.050     Document Type: Article

References (40)

1. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285 (2001) 2370-2375
2. Kannel W.B., Wolf P.A., Benjamin E.J., and Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82 (1998) 2N-9N
3. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., and Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Jama 271 (1994) 840-844
4. Wachtell K., Lehto M., Gerdts E., et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45 (2005) 712-719
5. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., and Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98 (1998) 946-952
6. Hart R.G., Halperin J.L., Pearce L.A., et al. Lessons from the stroke prevention in atrial fibrillation trials. Ann Intern Med 138 (2003) 831-838
7. Miyasaka Y., Barnes M.E., Bailey K.R., et al. Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study. J Am Coll Cardiol 49 (2007) 986-992
8. Ruigomez A., Johansson S., Wallander M.A., and Garcia Rodriguez L.A. Risk of mortality in a cohort of patients newly diagnosed with chronic atrial fibrillation. BMC Cardiovasc Disord 2 (2002) 5
9. Maisel W.H., and Stevenson L.W. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 91 (2003) 2D-8D
10. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., et al. Validity of the general practice research database. Pharmacotherapy 23 (2003) 686-689
11. Jick H., Jick S.S., and Derby L.E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302 (1991) 766-768
12. Lawrenson R., Todd J.C., Leydon G.M., Williams T.J., and Farmer R.D. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 49 (2000) 591-596
13. Huerta C., Johansson S., Wallander M.A., and Garcia Rodriguez L.A. Natural history of venous thromboembolism diagnosed in UK primary care. Arch Intern Med 167 (2006) 935-943
14. Meier C.R. Seasonal variations in the incidence of acute myocardial infarction. J Am Coll Cardiol 32 (1998) 2103-2104
15. Jick H., Derby L.E., Gurewich V., and Vasilakis C. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension. Pharmacotherapy 16 (1996) 321-326
16. Jick H., Jick S., Myers M.W., and Vasilakis C. Risk of acute myocardial infarction and low-dose combined oral contraceptives. Lancet 347 (1996) 627-628
17. Ruigomez A., Johansson S., Wallander M.A., and Garcia Rodriguez L.A. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord 5 (2005) 20
18. Ruigomez A., Johansson S., Wallander M.A., and Rodriguez L.A. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 55 (2002) 358-363
19. Ruigomez A., Garcia Rodriguez L.A., Johansson S., Wallander M.A., and Edvardsson N. Risk of cerebrovascular accident after a first diagnosis of atrial fibrillation. Clin Cardiol 30 (2007) 624-628
20. Scardi S., Mazzone C., Pandullo C., Goldstein D., Poletti A., and Humar F. Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up. Am Heart J 137 (1999) 686-691
21. Krahn A.D., Manfreda J., Tate R.B., Mathewson F.A., and Cuddy T.E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98 (1995) 476-484
22. Wachtell K., Hornestam B., Lehto M., et al. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45 (2005) 705-711
23. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur Heart J 27 (2006) 936-941
24. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22 (1991) 983-988
25. Chugh S.S., Blackshear J.L., Shen W.K., Hammill S.C., and Gersh B.J. Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol 37 (2001) 371-378
26. Berjon Reyero J., Olaz Preciado F., and de los Arcos Lage E. Epidemiology, risk factors, and pathogeny of atrial fibrillation and atrial flutter. Rev Esp Cardiol 49 Suppl 2 (1996) 1-7
27. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study. Stroke 36 (2005) 2362-2366
28. van Walraven C., Hart R.G., Wells G.A., et al. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Intern Med 163 (2003) 936-943
29. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. Jama 285 (2001) 2864-2870
30. Jahangir A., Lee V., Friedman P.A., et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study. Circulation 115 (2007) 3050-3056
31. Petersen P. Thromboembolic complications of atrial fibrillation and their prevention: a review. Am J Cardiol 65 (1990) 24C-28C
32. Atrial fibrillation investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
33. Hart R.G., Pearce L.A., Rothbart R.M., McAnulty J.H., Asinger R.W., and Halperin J.L. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke prevention in atrial fibrillation investigators. J Am Coll Cardiol 35 (2000) 183-187
34. Inoue H., and Atarashi H. Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation. Am J Cardiol 86 (2000) 852-855
35. Heist E.K., and Ruskin J.N. Atrial fibrillation and congestive heart failure: risk factors, mechanisms, and treatment. Prog Cardiovasc Dis 48 (2006) 256-269
36. Stewart S., Hart C.L., Hole D.J., and McMurray J.J. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 113 (2002) 359-364
37. Onundarson P.T., Thorgeirsson G., Jonmundsson E., Sigfusson N., and Hardarson T. Chronic atrial fibrillation-epidemiologic features and 14 year follow-up: a case control study. Eur Heart J 8 (1987) 521-527
38. Ridhaa M., Amina A.A., Saleha S.A., et al. The prevalence of atrial fibrillation among acute medical admissions in Kuwait. Med Princ Pract 14 (2005) 136-139
39. Gronefeld G.C., and Hohnloser S.H. Heart failure complicated by atrial fibrillation: mechanistic, prognostic, and therapeutic implications. J Cardiovasc Pharmacol Ther 8 (2003) 107-113
40. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27 (2006) 1979-2030